| 英文别名 |
2',6'-Dimethylacetanilide;2,6-Acetoxylidide;N-(2,6-Dimethylphenyl)acetamide;2′,6′-Dimethylacetanilide (Lidocaine RCC);2',6'-ACETOXYLIDIDE;2,6-Dimethylacetanilide;2,6-dimethyl-N-acetanilide;2′,6′-Dimethylacetanilide;Acetamide,N-(2,6-dimethylphenyl);N-(2,6-dimethylphenyl)-acetamide;N-Acetoxy-2,6-dimethylaniline;N-Acetyl-2,6-dimethylaniline;N-Acetyl-2,6-xylidine;2′,6′-Acetoxylidide;Acetamide, N-(2,6-dimethylphenyl)-;Acetanilide, 2',6'-dimethyl-;68GZI4J9FM;NRPTXWYBRKRZES-UHFFFAOYSA-N;N-(2,6-dimethyl-phenyl)-acetamide;2,6-Acetoxylide;NSC54130;Acetanilide,6'-dimethyl-;WLN: 1VMR B1 F1;J;Acetamide,N-(2,6-dimethylphenyl)-;UNII-68GZI4J9FM;N-(2, 6-dimethylphenyl)acetamide;BRN 2208750;BS-16053;SY061310;2',6'-Dimethylacetanilide (Lidocaine RCC), Pharmaceutical Secondary Standard; Certified Reference Material;EN300-154494;AKOS003237148;NS00027010;NSC 54130;2',6'-Dimethylacetanilide, 97%;N-(2,6-dimethylphenyl) acetamide;2,6-Acetoxylidide; N-(2,6-Dimethylphenyl)acetamide;EINECS 218-596-8;SB75738;Lidocaine Hydrochloride Imp. C (EP); Lidocaine Imp. C (EP); N-(2,6-Dimethylphenyl)-acetamide; Lidocaine Hydrochloride Impurity C; Lidocaine Impurity C;SCHEMBL436967;2198-53-0;NSC-54130;FT-0610511;InChI=1/C10H13NO/c1-7-5-4-6-8(2)10(7)11-9(3)12/h4-6H,1-3H3,(H,11,12;W-107511;?2',6'-DIMETHYLACETANILIDE;AE-562/40191128;MFCD00008675;DTXSID2062244;s10126;CGA42447;Q27264249;A878833;LIDOCAINE HYDROCHLORIDE IMPURITY C [EP IMPURITY];CS-0153429;LIDOCAINE IMPURITY C [EP IMPURITY];FT-0666891 |